This protocol is judged by an institutional evaluate board, an unbiased team that assessments any scientific trials involving human beings. If a review consists of a Agenda I drug, when the board approves the protocol as ethical, the researchers have to submit an application for an investigational new drug (IND) range with the FDA.Although the prot